Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation

William Reiley1, Minying Zhang, Xuefeng Wu

  • 1Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033, USA.

Insights

Tumor suppressor CYLD

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • CYLD is a deubiquitinating enzyme (DUB) that suppresses ubiquitination of signaling molecules like TRAF2.
  • The regulatory mechanisms governing CYLD's function are not fully understood.
  • Understanding CYLD regulation is crucial for its role in tumor suppression.

Purpose of the Study:

  • To investigate the regulatory mechanisms of the tumor suppressor CYLD.
  • To determine how CYLD's function in signaling pathways is controlled.
  • To identify upstream regulators of CYLD phosphorylation.

Main Methods:

  • Investigated CYLD phosphorylation in response to cellular stimuli.
  • Assessed the role of IkappaB kinase gamma (IKKgamma) in CYLD phosphorylation.
  • Analyzed the impact of CYLD phosphorylation on TRAF2 ubiquitination and downstream signaling.

Main Results:

  • Inducible phosphorylation of CYLD was identified as a key regulatory mechanism.
  • CYLD phosphorylation is transient and required for signal-induced TRAF2 ubiquitination.
  • CYLD phosphorylation is dependent on IKKgamma and induced by IKK catalytic subunits.

Conclusions:

  • CYLD phosphorylation by IKKgamma regulates its deubiquitinating activity.
  • Site-specific phosphorylation of CYLD by IKK controls its signaling function.
  • CYLD is a novel target of the IKK signaling pathway.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...